Vascepa and Abdominal pain lower - a phase IV clinical study of FDA data

Summary:

Abdominal pain lower is reported only by a few people who take Vascepa.

The phase IV clinical study analyzes which people take Vascepa and have Abdominal pain lower. It is created by eHealthMe based on reports of 4,499 people who have side effects while taking Vascepa from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

4,499 people reported to have side effects when taking Vascepa.
Among them, 2 people (0.04%) have Abdominal pain lower.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 4,590 Vascepa users for its effectiveness, alternative drugs and more.

What is Abdominal pain lower?

Abdominal pain lower is found to be associated with 2,546 drugs and 1,706 conditions by eHealthMe.

Number of Vascepa and Abdominal pain lower reports submitted per year:

Could Vascepa cause Abdominal pain lower?

Gender of people who have Abdominal pain lower when taking Vascepa *:

female: 100 %
male: 0.0 %

Common drugs people take besides Vascepa *:

Protonix: 2 people, 100.00%
Magnesium: 2 people, 100.00%
Diovan: 2 people, 100.00%
Calcium: 2 people, 100.00%

Common side effects people have besides Abdominal pain lower *:

Diarrhea: 2 people, 100.00%

Common conditions people have *:

Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 100.00%
High Blood Pressure: 2 people, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 100.00%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vascepa and have Abdominal pain lower?

Check whether Abdominal pain lower is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Abdominal pain lower and when was it recovered:

Abdominal pain lower in Vascepa

Expand to all the drugs that have ingredients of icosapent ethyl:

Abdominal pain lower and drugs with ingredients of icosapent ethyl

Alternative drugs to, pros and cons of Vascepa:

Vascepa (4,590 reports)

Common Vascepa side effects:

Diarrhea: 327 reports
Joint pain: 307 reports
Drug ineffective: 267 reports
High blood cholesterol: 261 reports
Fatigue (feeling of tiredness): 222 reports
Belching (release of gas from the digestive tract): 198 reports
Pain: 164 reports

Browse all side effects of Vascepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abdominal pain lower treatments and more:

Abdominal pain lower (27,701 reports)

COVID vaccines that are related to Abdominal pain lower:

Common drugs associated with Abdominal pain lower:

How the study uses the data?

The study uses data from the FDA. It is based on icosapent ethyl (the active ingredients of Vascepa) and Vascepa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.